Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FACTOR NKSF' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 139 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dinh, HKB; Zhao, BT; Schuschereba, ST; Merrill, G; Bowman, PD
      Gene expression profiling of the response to thermal injury in human cells

      PHYSIOLOGICAL GENOMICS
    2. Justo, GZ; Silva, MR; Queiroz, MLS
      Effects of the green algae Chlorella vulgaris on the response of the host hematopoietic system to intraperitoneal Ehrlich ascites tumor transplantation in mice

      IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
    3. Suh, YS; Ha, SJ; Lee, CH; Sin, JI; Sung, YC
      Enhancement of VP1-specific immune responses and protection against EMCV-Kchallenge by co-delivery of IL-12 DNA with VP1 DNA vaccine

      VACCINE
    4. Shin, T; Nakayama, T; Akutsu, Y; Motohashi, S; Shibata, Y; Harada, M; Kamada, N; Shimizu, C; Shimizu, E; Saito, T; Ochiai, T; Taniguchi, M
      Inhibition of tumor metastasis by adoptive transfer of IL-12-activated V alpha 14 NKT cells

      INTERNATIONAL JOURNAL OF CANCER
    5. Yun, PLW; DeCarlo, AA; Collyer, C; Hunter, N
      Hydrolysis of interleukin-12 by Porphyromonas gingivalis major cysteine proteinases may affect local gamma interferon accumulation and the Th1 or Th2T-cell phenotype in periodontitis

      INFECTION AND IMMUNITY
    6. Tatsumi, T; Takehara, T; Kanto, T; Miyagi, T; Kuzushita, N; Sugimoto, Y; Jinushi, M; Kasahara, A; Sasaki, Y; Hori, M; Hayashi, N
      Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma

      CANCER RESEARCH
    7. Tsuji-Yamada, J; Nakazawa, M; Takahashi, K; Iijima, K; Hattori, S; Okuda, K; Minami, M; Ikezawa, Z; Sasaki, T
      Effect of IL-12 encoding plasmid administration on tight-skin mouse

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    8. Luty, S; Latuszynska, J; Obuchowska-Przebirowska, D; Tokarska, M; Haratym-Maj, A
      Subacute toxicity of orally applied alpha-cypermethrin in Swiss mice

      ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE
    9. Gollob, JA; Mier, JW; Veenstra, K; McDermott, DF; Clancy, D; Clancy, M; Atkins, MB
      Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: Ability to maintain IFN-gamma induction is associated with clinical response

      CLINICAL CANCER RESEARCH
    10. Sin, JI; Kim, J; Patchuk, C; Weiner, DB
      Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    11. Pan, L; Ohnishi, K; Zhang, WJ; Yoshida, H; Maksumova, L; Muratkhodjaev, F; Shigeno, K; Nakamura, S; Luo, JM; Hao, HL; Fujisawa, S; Naito, K; Shinjo, K; Takeshita, A; Ohno, R
      In vitro IL-12 treatment of peripheral blood mononuclear cells from patients with leukemia or myelodysplastic syndromes: increase in cytotoxicity andreduction in WT1 gene expression

      LEUKEMIA
    12. Marana, HRC; da Silva, JS; de Andrade, JM
      NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer

      GYNECOLOGIC ONCOLOGY
    13. Eto, M; Harada, M; Tamada, K; Tokuda, N; Koikawa, Y; Nakamura, M; Nomoto, K; Naito, S
      Antitumor activity of interleukin-12 against murine bladder cancer

      JOURNAL OF UROLOGY
    14. Chakir, H; Camilucci, AA; Filion, LG; Webb, JR
      Differentiation of murine NK cells into distinct subsets based on variableexpression of the IL-12R beta 2 subunit

      JOURNAL OF IMMUNOLOGY
    15. Grufman, P; Karre, K
      Innate and adaptive immunity to tumors: IL-12 is required for optimal responses

      EUROPEAN JOURNAL OF IMMUNOLOGY
    16. Wang, KS; Frank, DA; Ritz, J
      Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4

      BLOOD
    17. Ulchaker, J; Panuto, J; Rayman, P; Novick, A; Elson, P; Tubbs, R; Finke, JH; Bukowski, RM
      Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: Evidence of impaired secretion in response to interleukin-12

      JOURNAL OF IMMUNOTHERAPY
    18. Bukowski, RM; Rayman, P; Molto, L; Tannenbaum, CS; Olencki, T; Peereboom, D; Tubbs, R; McLain, D; Budd, GT; Griffin, T; Novick, A; Hamilton, TA; Finke, J
      Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma

      CLINICAL CANCER RESEARCH
    19. Yamanaka, K; Hara, I; Nagai, H; Miyake, H; Gohji, K; Micallef, MJ; Kurimoto, M; Arakawa, S; Kamidono, S
      Synergistic antitumor effects of interleukin-12 gene transfer and systemicadministration of interleukin-18 in a mouse bladder cancer model

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    20. Zagozdzon, R; Giermasz, A; Golab, J; Stoklosa, T; Jalili, A; Jakobisiak, M
      The potentiated antileukemic effects of doxorubicin and interleukin-12 combination are not dependent on nitric oxide production

      CANCER LETTERS
    21. Tatsumi, T; Takehara, T; Kanto, T; Kuzushita, N; Ito, A; Kasahara, A; Sasaki, Y; Hori, M; Hayashi, N
      B7-1 (CD80)-gene transfer combined with interleukin-12 administration elicits protective and therapeutic immunity against mouse hepatocellular carcinoma

      HEPATOLOGY
    22. Takada, T; Kato, K; Yagita, H; Hamada, H; Okumura, K
      Effects of immunization with tumor cells double transfected with interleukin-2 (IL-2) and interleukin-12 (IL-12) genes on artificial metastasis of colon26 cells in BALB c mice

      CLINICAL & EXPERIMENTAL METASTASIS
    23. Phillips, BS; Padilla, ML; Dickerson, EB; Lindstrom, MJ; Helfand, SC
      Immunostimulatory effects of human recombinant interleukin-12 on peripheral blood mononuclear cells from normal dogs

      VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
    24. Sin, JI; Kim, JJ; Boyer, JD; Ciccarelli, RB; Higgins, TJ; Weiner, DB
      In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model

      JOURNAL OF VIROLOGY
    25. Gollob, JA; Schnipper, CP; Murphy, EA; Ritz, J; Frank, DA
      The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation

      JOURNAL OF IMMUNOLOGY
    26. Sin, JI; Kim, JJ; Arnold, RL; Shroff, KE; McCallus, D; Pachuk, C; McElhiney, SP; Wolf, MW; Pompa-de Bruin, SJ; Higgins, TJ; Ciccarelli, RB; Weiner, DB
      IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge

      JOURNAL OF IMMUNOLOGY
    27. Marinaro, M; Boyaka, PN; Jackson, RJ; Finkelman, FD; Kiyono, H; Jirillo, E; McGhee, JR
      Use of intranasal IL-12 to target predominantly Th1 responses to nasal andTh2 responses to oral vaccines given with cholera toxin

      JOURNAL OF IMMUNOLOGY
    28. Facchetti, P; Tacchetti, C; Prigione, I; Airoldi, I; Favre, A; Grossi, CE; Pistoia, V
      Ultrastructural and functional studies of the interaction between IL-12 and IL-2 for the generation of lymphokine-activated killer cells

      EXPERIMENTAL CELL RESEARCH
    29. Yue, FY; Geertsen, R; Hemmi, S; Burg, G; Pavlovic, J; Laine, E; Dummer, R
      IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity?

      EUROPEAN JOURNAL OF IMMUNOLOGY
    30. UNO K; SETOGUCHI J; TANIGAWA M; KISHI A; OGAWA M; SAOTOME H; FUJIWARA H; KISHIDA T
      DIFFERENTIAL INTERLEUKIN-12 RESPONSIVENESS FOR INTERFERON-GAMMA PRODUCTION IN ADVANCED STAGES OF CANCER-PATIENTS CORRELATES WITH PERFORMANCE STATUS

      Clinical cancer research
    31. PAI K; YANAGAWA H; TAKAUCHI E; SUZUKI Y; HANIBUCHI M; PARAJULI P; SONE S
      DIFFERENTIAL EFFECT OF INTERLEUKIN-10 ON INTERLEUKIN-12-MEDIATED AND INTERLEUKIN-2-MEDIATED KILLER INDUCTION FROM BLOOD MONONUCLEAR-CELLS

      Oncology research
    32. GOLAB J; STOKLOSA T; ZAGOZDZON R; KACA A; GIERMASZ A; POJDA Z; MACHAJ E; DABROWSKA A; FELESZKO W; LASEK W; IWANOSIECKA A; JAKOBISIAK M
      G-CSF PREVENTS THE SUPPRESSION OF BONE-MARROW HEMATOPOIESIS INDUCED BY IL-12 AND AUGMENTS ITS ANTITUMOR-ACTIVITY IN A MELANOMA MODEL IN MICE

      Annals of oncology
    33. Nowicka, D; Zagozdzon, R; Majewski, S; Marczak, M; Jablonska, S; Bollag, W
      Calcitriol enhances antineoplastic and antiangiogenic effects of interleukin-12

      ARCHIVES OF DERMATOLOGICAL RESEARCH
    34. AHN HJ; TOMURA M; YU WG; IWASAKI M; PARK WR; HAMAOKA T; FUJIWARA H
      REQUIREMENT FOR DISTINCT JANUS KINASES AND STAT PROTEINS IN T-CELL PROLIFERATION VERSUS IFN-GAMMA PRODUCTION FOLLOWING IL-12 STIMULATION

      The Journal of immunology (1950)
    35. GOLLOB JA; SCHNIPPER CP; ORSINI E; MURPHY E; DALEY JF; LAZO SB; FRANK DA; NEUBERG D; RITZ J
      CHARACTERIZATION OF A NOVEL SUBSET OF CD8(-CELLS THAT EXPANDS IN PATIENTS RECEIVING INTERLEUKIN-12() T)

      The Journal of clinical investigation
    36. HARADA M; TAMADA K; ABE K; LI TL; ONOE Y; TADA H; TAKENOYAMA M; YASUMOTO K; KIMURA G; NOMOTO K
      SYSTEMIC ADMINISTRATION OF INTERLEUKIN-12 CAN RESTORE THE ANTITUMOR POTENTIAL OF B16 MELANOMA-DRAINING LYMPH-NODE CELLS IMPAIRED AT A LATE TUMOR-BEARING STATE

      International journal of cancer
    37. MILLER MA; SKEEN MJ; ZIEGLER HK
      LONG-LIVED PROTECTIVE IMMUNITY TO LISTERIA IS CONFERRED BY IMMUNIZATION WITH PARTICULATE OR SOLUBLE LISTERIAL ANTIGEN PREPARATIONS COADMINISTERED WITH IL-12

      Cellular immunology
    38. OGAWA M; YU WG; UMEHARA K; IWASAKI M; WIJESURIYA R; TSUJIMURA T; KUBO T; FUJIWARA H; HAMAOKA T
      MULTIPLE ROLES OF INTERFERON-GAMMA IN THE MEDIATION OF INTERLEUKIN 12-INDUCED TUMOR-REGRESSION

      Cancer research
    39. GELDHOF AB; MOSER M; LESPAGNARD L; THIELEMANS K; DEBAETSELIER P
      INTERLEUKIN-12-ACTIVATED NATURAL-KILLER-CELLS RECOGNIZE B7 COSTIMULATORY MOLECULES ON TUMOR-CELLS AND AUTOLOGOUS DENDRITIC CELLS

      Blood
    40. HIASA Y; HORIIKE N; AKBAR SMF; SAITO I; MIYAMURA T; MATSUURA Y; ONJI M
      LOW STIMULATORY CAPACITY OF LYMPHOID DENDRITIC CELLS EXPRESSING HEPATITIS-C VIRUS GENES

      Biochemical and biophysical research communications (Print)
    41. ATKINS MB; ROBERTSON MJ; GORDON M; LOTZE MT; DECOSTE M; DUBOIS JS; RITZ J; SANDLER AB; EDINGTON HD; GARZONE PD; MIER JW; CANNING CM; BATTIATO L; TAHARA H; SHERMAN ML
      PHASE-I EVALUATION OF INTRAVENOUS RECOMBINANT HUMAN INTERLEUKIN-12 INPATIENTS WITH ADVANCED MALIGNANCIES

      Clinical cancer research
    42. PIZZOFERRATO E; CHU NR; HAWLEY TS; LIEU FHL; BARBER BH; HAWLEY RG; WATTS TH; BERINSTEIN NL
      ENHANCED IMMUNOGENICITY OF B-CELL LYMPHOMA GENETICALLY-ENGINEERED TO EXPRESS BOTH B7-1 AND INTERLEUKIN-12

      Human gene therapy
    43. SARINA B; CORTELEZZI A; CATTANEO C; POMATI M; SILVESTRIS I; DISTEFANO M; LAMBERTENGHIDELILIERS D; HU C; MONZA M; MAIOLO AT
      IN-VITRO EFFECTS OF IL-12 AND IL-2 ON NK CELLS, CYTOKINE RELEASE AND CLONOGENIC ACTIVITY IN MYELODYSPLASTIC SYNDROMES (MDS)

      Leukemia
    44. MARUO S; AHN HJ; YU WG; TOMURA M; WYSOCKA M; YAMAMOTO N; KOBAYASHI M; HAMAOKA T; TRINCHIERI G; FUIJIWARA H
      ESTABLISHMENT OF AN IL-12-RESPONSIVE T-CELL CLONE - ITS CHARACTERIZATION AND UTILIZATION IN THE QUANTITATION OF IL-12 ACTIVITY

      Journal of leukocyte biology
    45. CARTER RW; PATEL PM; STANLEY AJ; INGHAM E; WADHWA M; BIRD C; THORPE R; SELBY PJ; BANKS RE
      PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES TO HUMAN INTERLEUKIN-12

      Hybridoma
    46. ZAGOZDZON R; STOKLOSA T; GOLAB J; GIERMASZ A; DABROWSKA A; LASEK W; JAKOBISIAK M
      AUGMENTED ANTITUMOR EFFECTS OF COMBINATION THERAPY WITH INTERLEUKIN-12, CISPLATIN, AND TUMOR-NECROSIS-FACTOR-ALPHA IN A MURINE MELANOMA MODEL

      Anticancer research
    47. STEGER GG; GNANT MF; DJAVANMARD MP; MADER RM; JAKESZ R; PIERCE W; DEKERNION JB; FIGLIN R; BELLDEGRUN A
      THE IN-VITRO EFFECTS OF INTERLEUKIN-12 UPON TUMOR-INFILTRATING LYMPHOCYTES DERIVED FROM RENAL-CELL CARCINOMA

      Journal of cancer research and clinical oncology
    48. TSUTSUI T; MU J; OGAWA M; YU WG; SUDA T; NAGAGA S; SAJI F; MURATA Y; FUJIWARA H; HAMAOKA T
      ADMINISTRATION OF IL-12 INDUCES A CD3(-)CD8(-)B220(+) LYMPHOID POPULATION CAPABLE OF ELICITING CYTOLYSIS AGAINST FAS-POSITIVE TUMOR-CELLS()CD4()

      The Journal of immunology
    49. CHEN L; CHEN DS; BLOCK E; ODONNELL M; KUFE DW; CLINTON SK
      ERADICATION OF MURINE BLADDER-CARCINOMA BY INTRATUMOR INJECTION OF A BICISTRONIC ADENOVIRAL VECTOR CARRYING CDNAS FOR THE IL-12 HETERODIMERAND ITS INHIBITION BY THE IL-12 P40 SUBUNIT HOMODIMER

      The Journal of immunology
    50. MARUO S; OHHORA M; AHN HJ; ONO S; WYSOCKA M; KANEKO Y; YAGITA H; OKUMURA K; KIKUTANI H; KISHIMOTO T; KOBAYASHI M; HAMAOKA T; TRINCHIERI G; FUJIWARA H
      B-CELL REGULATE CD40 LIGAND-INDUCED IL-12 PRODUCTION IN ANTIGEN-PRESENTING CELLS (APC) DURING T-CELL APC INTERACTIONS/

      The Journal of immunology
    51. OGAWA M; TSUTSUI T; ZOU JP; MU J; WIJESURIYA R; YU WG; HERRMANN S; KUBO T; FUJIWARA H; HAMAOKA T
      ENHANCED INDUCTION OF VERY LATE ANTIGEN 4 LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN 1-DEPENDENT T-CELL MIGRATION TO TUMOR SITES FOLLOWING ADMINISTRATION OF INTERLEUKIN-12/

      Cancer research
    52. BONNOTTE B; BURDILES AM; CHEHIMI J; CARAYOL G; PARDOUX C; DIETRICH PY; KUBIN M; BLAY JY; CAIGNARD A; IBRAHIM A; ROBINET E; HAYAT M; PICO JL; BOURHIS JH; CHOUAIB S
      SERUM INTERLEUKIN-12 LEVELS IN PATIENTS UNDERGOING ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      European cytokine network
    53. IZQUIERDO MA; DEGEN D; SYPEK JP; VONHOFF DD
      ANTIPROLIFERATIVE EFFECTS OF INTERLEUKIN-12 TREATMENT ON HUMAN TUMOR COLONY-FORMING-UNITS TAKEN DIRECTLY FROM PATIENTS

      Anti-cancer drugs
    54. HORVATHARCIDIACONO JA; MOSTOWSKI HS; BLOOM ET
      IL-12 ADMINISTERED IN-VIVO TO YOUNG AND AGED MICE - DISCREPANCY BETWEEN THE EFFECTS ON TUMOR-GROWTH IN-VIVO AND CYTOTOXIC T-LYMPHOCYTE GENERATION EX-VIVO - DEPENDENCE ON IFN-GAMMA

      International immunology
    55. HELLQUIST HB; KARLSSON MG; VIALE G; KARLSSON C; DAVIDSSON A; DELLORTO P; OLOFSSON J
      BCL-2 IMMUNOREACTIVITY IN SALIVARY-GLAND NEOPLASMS IS UNRELATED TO THE EXPRESSION OF MESSENGER-RNA FOR NATURAL-KILLER-CELL STIMULATORY CYTOKINES INTERLEUKIN (IL)-2 AND IL-12

      Virchows Archiv
    56. VANBERGEN CAM; SMIT WM; VANSLUIJTERS DA; RIJNBEEK M; WILLEMZE R; FALKENBURG JHF
      INTERLEUKIN-10, INTERLEUKIN-12, AND TUMOR-NECROSIS-FACTOR-ALPHA DIFFERENTIALLY INFLUENCE THE PROLIFERATION OF HUMAN CD8(-CELL CLONES() AND CD4(+) T)

      Annals of hematology
    57. KITAGUCHI T; NAGOYA M; AMANO T; SUZUKI M; MINAMI M
      ANALYSIS OF ROLES OF NATURAL-KILLER-CELLS IN DEFENSE AGAINST PLASMODIUM-CHABAUDI IN MICE

      Parasitology research
    58. PERALES MA; SKOLNIK PR; LIEBERMAN J
      EFFECT OF INTERLEUKIN-12 ON IN-VITRO HIV TYPE-1 REPLICATION DEPENDS ON CLINICAL STAGE

      AIDS research and human retroviruses
    59. RASHLEIGH SP; KUSHER DI; ENDICOTT JN; ROSSI AR; DJEU JY
      INTERLEUKIN-2 AND INTERLEUKIN-12 ACTIVATE NATURAL-KILLER CYTOLYTIC RESPONSES OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMAE

      Archives of otolaryngology, head & neck surgery
    60. CHOUAIB S; CHEHIMI J
      HUMAN INTERLEUKIN-12 BIOLOGICAL ROLE AND THERAPEUTIC POTENTIAL

      MS. Medecine sciences
    61. TRINCHIERI G; GEROSA F
      IMMUNOREGULATION BY INTERLEUKIN-12

      Journal of leukocyte biology
    62. SAHIN U; KRAFTBAUER S; OHNESORGE S; PFREUNDSCHUH M; RENNER C
      INTERLEUKIN-12 INCREASES BISPECIFIC-ANTIBODY-MEDIATED NATURAL-KILLER-CELL CYTOTOXICITY AGAINST HUMAN TUMORS

      Cancer immunology and immunotherapy
    63. DWYER DS
      MOLECULAR-MODEL OF INTERLEUKIN-12 THAT HIGHLIGHTS AMINO-ACID-SEQUENCEHOMOLOGIES WITH ADHESION DOMAINS AND GASTROINTESTINAL PEPTIDES

      Journal of molecular graphics
    64. MARANA HRC; ANDRADE JM; SILVA JS
      NATURAL-KILLER-CELLS AND INTERLEUKIN-12 IN PATIENTS WITH ADVANCED CERVICAL-CANCER UNDER NEOADJUVANT CHEMOTHERAPY

      Brazilian journal of medical and biological research
    65. CARUSO M; PHAMNGUYEN K; KWONG YL; XU BS; KOSAI KI; FINEGOLD M; WOO SLC; CHEN SH
      ADENOVIRUS-MEDIATED INTERLEUKIN-12 GENE-THERAPY FOR METASTATIC COLON-CARCINOMA

      Proceedings of the National Academy of Sciences of the United Statesof America
    66. AKRIDGE RE; REED SG
      INTERLEUKIN-12 DECREASES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN HUMAN MACROPHAGE CULTURES RECONSTITUTED WITH AUTOLOGOUS PERIPHERAL-BLOOD MONONUCLEAR-CELLS

      The Journal of infectious diseases
    67. SATOH M; SEKI S; HASHIMOTO W; OGASAWARA K; KOBAYASHI T; KUMAGAI K; MATSUNO S; TAKEDA K
      CYTOTOXIC GAMMA-DELTA OR ALPHA-BETA T-CELLS WITH A NATURAL-KILLER-CELL MARKER, CD56, INDUCED FROM HUMAN PERIPHERAL-BLOOD LYMPHOCYTES BY A COMBINATION OF IL-12 AND IL-2

      The Journal of immunology
    68. AZZONI L; KANAKARAJ P; ZATSEPINA O; PERUSSIA B
      IL-12-INDUCED ACTIVATION OF NK AND T-CELLS OCCURS IN THE ABSENCE OF IMMEDIATE-EARLY ACTIVATION GENE-EXPRESSION

      The Journal of immunology
    69. GOLLOB JA; LI J; KAWASAKI H; DALEY JF; GROVES C; REINHERZ EL; RITZ J
      MOLECULAR INTERACTION BETWEEN CD58 AND CD2 COUNTER-RECEPTORS MEDIATESTHE ABILITY OF MONOCYTES TO AUGMENT T-CELL ACTIVATION BY IL-12

      The Journal of immunology
    70. PICCOTTI JR; CHAN SY; GOODMAN RE; MAGRAM J; EICHWALD EJ; BISHOP DK
      IL-12 ANTAGONISM INDUCES T-HELPER 2 RESPONSES, YET EXACERBATES CARDIAC ALLOGRAFT-REJECTION - EVIDENCE AGAINST A DOMINANT PROTECTIVE ROLE FOR T-HELPER 2 CYTOKINES IN ALLOIMMUNITY

      The Journal of immunology
    71. MARUO S; TOYOOKA K; OHHORA M; TAI XG; IWATA H; TAKENAKA H; YAMADA S; ONO S; HAMAOKA T; KOBAYASHI M; WYSOCKA M; TRINCHIERI G; FUJIWARA H
      IL-12 PRODUCED BY ANTIGEN-PRESENTING CELLS INDUCES IL-2-INDEPENDENT PROLIFERATION OF T-HELPER CELL CLONES

      The Journal of immunology
    72. BENJAMIN D; SHARMA V; KUBIN M; KLEIN JL; SARTORI A; HOLLIDAY J; TRINCHIERI G
      IL-12 EXPRESSION IN AIDS-RELATED LYMPHOMA B-CELL LINES

      The Journal of immunology
    73. TANNENBAUM CS; WICKER N; ARMSTRONG D; TUBBS R; FINKE J; BUKOWSKI RM; HAMILTON TA
      CYTOKINE AND CHEMOKINE EXPRESSION IN TUMORS OF MICE RECEIVING SYSTEMIC THERAPY WITH IL-12

      The Journal of immunology
    74. KATO T; HAKAMADA R; YAMANE H; NARIUCHI H
      INDUCTION OF IL-12 P40 MESSENGER-RNA EXPRESSION AND IL-12 PRODUCTION OF MACROPHAGES VIA CD40-CD40 LIGAND INTERACTION

      The Journal of immunology
    75. MA XJ; CHOW JM; GRI G; CARRA G; GEROSA F; WOLF SE; DZIALO R; TRINCHIERI G
      THE INTERLEUKIN-12 P40 GENE PROMOTER IS PRIMED BY INTERFERON-GAMMA INMONOCYTIC CELLS

      The Journal of experimental medicine
    76. BHARDWAJ N; SEDER RA; REDDY A; FELDMAN MV
      IL-12 IN CONJUNCTION WITH DENDRITIC CELLS ENHANCES ANTIVIRAL CD8-VITRO( CTL RESPONSES IN)

      The Journal of clinical investigation
    77. SALVUCCI O; MAMICHOUAIB F; MOREAU JL; THEZE J; CHEHIMI J; CHOUAIB S
      DIFFERENTIAL REGULATION OF INTERLEUKIN-12-INDUCED AND INTERLEUKIN-15-INDUCED NATURAL-KILLER-CELL ACTIVATION BY INTERLEUKIN-4

      European Journal of Immunology
    78. BONNOTTE B; PARDOUX C; BOURHIS JH; CAIGNARD A; BURDILES AM; CHEHIMI J; MAMICHOUAIB F; CHOUAIB S
      INHIBITION OF THE HUMAN ALLOGENEIC MIXED LYMPHOCYTE-RESPONSE BY CYCLOSPORINE-A - RELATIONSHIP WITH THE IL-12 PATHWAY

      Tissue antigens
    79. TRINCHIERI G
      INTERLEUKIN-12 - CLINICAL POTENTIAL IN INFECTIOUS-DISEASES, AIDS AND CANCER

      CLINICAL IMMUNOTHERAPEUTICS
    80. BARTON DPJ; BLANCHARD DK; DUAN C; ROBERTS WS; CAVANAGH D; DECESARE S; DJEU JY
      INTERLEUKIN-12 SYNERGIZES WITH INTERLEUKIN-2 TO GENERATE LYMPHOKINE-ACTIVATED KILLER ACTIVITY IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS CULTURED IN OVARIAN-CANCER ASCITIC FLUID

      Journal of the Society for Gynecologic Investigation
    81. HIRAO A; TAKAUE Y; KAWANO Y; SATO J; SUZUE T; ABE T; SAITO S; KAWAHITO M; OKAMOTO Y; MAKIMOTO A; KURODA Y
      SYNERGISM OF INTERLEUKIN-12, INTERLEUKIN-3 AND SERUM FACTOR ON PRIMITIVE HUMAN HEMATOPOIETIC PROGENITOR CELLS

      Stem cells
    82. VERBIK DJ; JOSHI SS
      IMMUNE CELLS AND CYTOKINES - THEIR ROLE IN CANCER-IMMUNOTHERAPY (REVIEW)

      International journal of oncology
    83. TAHARA H; LOTZE MT
      ANTITUMOR EFFECTS OF INTERLEUKIN-12 (IL-12) - APPLICATIONS FOR THE IMMUNOTHERAPY AND GENE-THERAPY OF CANCER

      Gene therapy
    84. HAKU T; SONE S; NABIOULLIN R; OGURA T
      HUMAN ALVEOLAR MACROPHAGES AUGMENT NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12)-INDUCIBLE KILLER ACTIVITY FROM AUTOLOGOUS BLOOD-LYMPHOCYTES

      Japanese journal of cancer research
    85. VERMA UN; MAZUMDER A
      INTERLEUKIN-12 (IL-12) ALONE OR IN SYNERGISTIC COMBINATION WITH IL-2 FOR IN-VITRO ACTIVATION OF HUMAN BONE-MARROW - DIFFERENTIAL-EFFECTS ATDIFFERENT TIME POINTS

      Bone marrow transplantation
    86. HISCOX S; HALLETT MB; PUNTIS MCA; JIANG WG
      INHIBITION OF CANCER CELL MOTILITY AND INVASION BY INTERLEUKIN-12

      Clinical & experimental metastasis
    87. FUJIWARA H; HAMAOKA T
      REGULATORY MECHANISMS OF ANTITUMOR T-CELL RESPONSES IN THE TUMOR-BEARING STATE

      Immunologic research
    88. BLOOM ET; THOMPSON WC; HORVATHARCIDIACONO JA; BURD PR
      DIFFERENTIAL-EFFECTS OF INTERLEUKIN-12 TREATMENT ON GENE-EXPRESSION BY ALLOSTIMULATED T-CELLS FROM YOUNG AND AGED MICE

      Mechanism of ageing and development
    89. NICKBARG EB; VATH JE; PITTMAN DD; LEONARD JE; WALDBURGER KE; BOND MD
      STRUCTURAL CHARACTERIZATION OF THE RECOMBINANT P40 HEAVY-CHAIN SUBUNIT MONOMER AND HOMODIMER OF MURINE IL-12

      Bioorganic chemistry
    90. MILLER MA; SKEEN MJ; ZIEGLER HK
      NONVIABLE BACTERIAL-ANTIGENS ADMINISTERED WITH IL-12 GENERATE ANTIGEN-SPECIFIC T-CELL RESPONSES AND PROTECTIVE IMMUNITY AGAINST LISTERIA-MONOCYTOGENES

      The Journal of immunology
    91. JELINEK DF; BRAATEN JK
      ROLE OF IL-12 IN HUMAN B-LYMPHOCYTE PROLIFERATION AND DIFFERENTIATION

      The Journal of immunology
    92. DYBEDAL I; LARSEN S; JACOBSEN SEW
      IL-12 DIRECTLY ENHANCES IN-VITRO MURINE ERYTHROPOIESIS IN COMBINATIONWITH IL-4 AND STEM-CELL FACTOR

      The Journal of immunology
    93. LING P; GATELY MK; GUBLER U; STERN AS; LIN P; HOLLFELDER K; SU C; PAN YCE; HAKIMI J
      HUMAN IL-12 P40 HOMODIMER BINDS TO THE IL-12 RECEPTOR BUT DOES NOT MEDIATE BIOLOGIC ACTIVITY

      The Journal of immunology
    94. GOLLOB JA; LI J; REINHERZ EL; RITZ J
      CD2 REGULATES RESPONSIVENESS OF ACTIVATED T-CELLS TO INTERLEUKIN-12

      The Journal of experimental medicine
    95. FLESCH IEA; HESS JH; HUANG S; AGUET M; ROTHE J; BLUETHMANN H; KAUFMANN SHE
      EARLY INTERLEUKIN-12 PRODUCTION BY MACROPHAGES IN RESPONSE TO MYCOBACTERIAL INFECTION DEPENDS ON INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA

      The Journal of experimental medicine
    96. ENG VM; CAR BD; SCHNYDER B; LORENZ M; LUGLI S; AGUET M; ANDERSON TD; RYFFEL B; QUESNIAUX VFJ
      THE STIMULATORY EFFECTS OF INTERLEUKIN (IL)-12 ON HEMATOPOIESIS ARE ANTAGONIZED BY IL-12-INDUCED INTERFERON-GAMMA IN-VIVO

      The Journal of experimental medicine
    97. ZOU JJ; SCHOENHAUT DS; CARVAJAL DM; WARRIER RR; PRESKY DH; GATELY MK; GUBLER U
      STRUCTURE-FUNCTION ANALYSIS OF THE P35 SUBUNIT OF MOUSE INTERLEUKIN-12

      The Journal of biological chemistry
    98. OBANA S; MIYAZAWA H; HARA E; TAMURA T; NARIUCHI H; TAKATA M; FUJIMOTO S; YAMAMOTO H
      INDUCTION OF ANTITUMOR IMMUNITY BY MOUSE-TUMOR CELLS TRANSFECTED WITHMOUSE INTERLEUKIN-12 GENE

      Japanese Journal of Medical Science & Biology
    99. BRIGHT JJ; KAUSALYA S; KHAR A
      NATURAL-KILLER-CELL ACTIVATION-ASSOCIATED INDUCTION OF TARGET-CELL DNA FRAGMENTATION IN A SPONTANEOUSLY REGRESSING RAT HISTIOCYTOMA

      Immunology
    100. PIGNATA C; PRASAD KVS; HALLEK M; DRUKER B; RUDD CE; ROBERTSON MJ; RITZ J
      PHOSPHORYLATION OF SRC FAMILY LCK TYROSINE KINASE FOLLOWING INTERLEUKIN-12 ACTIVATION OF HUMAN NATURAL-KILLER-CELLS

      Cellular immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 16:57:53